VEGFR-2/AURKA-IN-1
Product Specifications
Target
Aurora Kinase|||VEGFR
Related Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors|||Cell Cycle/Checkpoint|||Chromatin/Epigenetic
Bioactivity
VEGFR-2/AURKA-IN-1 (compound 5e) is a thiazolidin-4-one derivative with antitumor activity against glioma (IC50: 6.43 ?M in LN229 cells) . This compound exhibits affinity for AURKA and VEGFR-2, acting as a potential ligand. VEGFR-2/AURKA-IN-1 induces DNA strand breaks, showcasing cytotoxicity and anticancer potential.
Molecular Formula
C20H15ClF6N2O4S
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
L2020-73N-ML490 100 µL
Leucine Rich Repeat and Ig Domain Containing 1, NT (Leucine-rich Repeat and Immunoglobulin-like Domain-containing Nogo Receptor-interacting Protein 1, Lingo 1, LINGO1, Lingo-1, FLJ14594, Leucine-rich Repeat and Immunoglobilin Domain-containing Protein 1, Leucine-rich Repeat Neuronal Protein 1, LERN1, Leucine-rich Repeat Neuronal Protein 6A, LRRN6A, MGC17422, UNQ201/PRO227) (MaxLight 490) discontinued
Ask
View Details